Come join my new Data Science & AI team for #neuropsychiatry at Johnson & Johnson Innovative Medicine - we’re now hiring for:
Senior Manager, R&D Data, Data Science, and AI – Digital Health for Neuropsychiatry
https://t.co/5RUdz9rsvu
@BillAckman Shame on you @MIT, @Harvard, and @Upenn!
You shouldn’t need “context” to clearly denounce students who call for genocide of any group of fellow human beings, including based on religion, ethnicity, gender, sexuality, or anything else!
@ryangrim@ryangrim If it’s so obvious that the Squad members condemn such acts, then let them come out and clearly state that. Why is it so hard for them to do that, even if they don’t agree with Israel’s subsequent response.
@ryangrim@ryangrim Unfortunately, you are being self-evidently naive about this. If everyone in the world condemned such horrific actions, then Hamas and other terrorist groups would not commit such acts in the first place.
@ryangrim@ryangrim, on CNN you said you hope that everyone in the world condemns the use of sexual violence as a weapon. You used that as way to say that it’s not necessary that members of the Squad actually bother denouncing the horrific acts committed by Hamas.
Its #TransposonTuesday! Sharing our latest pre-print on the relationship between LINE-1 (L1), an ancient genome parasite, and p53, the most mutated gene in cancer. Led by our Alexander Solovyov @CompOncMSK, Julie Behr & @tmfromer @rome_tx
👇👇👇
https://t.co/LyMSYPa4S7
And here it is: 20+ years after the mapping of the human genome the complete #T2T mapping which will help illuminate vast unknown regions of the #darkgenome and how it impacts human health and disease. Congrats to the authors on this major scientific advancement.
Join our #DataScience team at ROME Therapeutics!
We have #CompBio / #MachineLearning positions to build a #repeatomics platform to develop drugs for autoimmune diseases & cancers:
https://t.co/ZpFFU32rhV
https://t.co/IqYFhPNi8l
https://t.co/1qyIEpAQt6
https://t.co/3eE58f992D
Very proud of my former team’s great work at #VerilyLifeSciences
“Toward a Mobile Platform for Real-world Digital Measurement of Depression: User-Centered Design, Data Quality, and Behavioral and Clinical Modeling”
Congratulations!! https://t.co/SE25aykGMO
Come join me in building up the #datascience team at ROME Therapeutics!
We are looking for experienced Data Science and technical leaders to work together in creating a scalable repeat profiling platform that innovates in the #computationalbiology and #m…https://t.co/Y69lwJTAkl
Excited to be taking part in this upcoming webinar (March 3), hosted by @googlecloud and @verilylifesci, titled "Leveraging Technology for a Healthy and Productive Return to Work"!
https://t.co/nsYMXAmcZV
Article I wrote with colleagues @califf001 and Sarah Poole on how a deliberate combination of vaccination, testing, mask wearing, hand washing, and social distancing will allow us to get back to normal more quickly than any of these alone!
Opinion: Instead of solely "waiting on the vaccines," by using nonpharmaceutical interventions and rational testing in combination with vaccination we can return to work and school more quickly and safely. https://t.co/mAapYyWKeM
Opinion: Instead of solely "waiting on the vaccines," by using nonpharmaceutical interventions and rational testing in combination with vaccination we can return to work and school more quickly and safely. https://t.co/mAapYyWKeM
Our new paper highlights the role of epidemiological modeling in supporting a holistic approach for suppressing #COVID19 spread in workplaces & universities. Learn more: https://t.co/FDCtVTAzqd
Amber was an early-stage mental health project exploring new ways to better measure and monitor mental health. The team recently wrapped up their work and today we’re making Amber’s technology and research findings available to the mental health community. https://t.co/nMdavE1ROQ
Thank you to the organizers for inviting me to give a keynote lecture today at the wonderful Harvard Computational Data Neuroscience Symposium:
https://t.co/LUQGh3EXQ5